EVGN Reports $4.6M Revenue, $0.06 EPS, Expands Pharma Collaborations, Advances ChemPass AI, Discontinues Lavie Bio Operations
EVOGENE LTD. · Now $0.68
-3.7% in 1d after detection
Post-detection moves
1h
—
1d
-3.7%
3d
-1.5%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS